Skip to main content
Premium Trial:

Request an Annual Quote

Bruker AXS, GE Healthcare, Chemical Computing Group, Frank Burgaezy, Roger Durst, Bernard Kolodziej, Ian Currie

Premium

New Products

Bruker AXS announced this week the release of Axiom 200, a digital imaging detector of macromolecular X-ray crystallography. The detector is based on Bruker's microgap detector technology. According to the company, the Axiom has essentially zero detector noise, and is able to record each individual X-ray photon as it strikes the detector, thus offering higher sensitivity than older analog detectors, such as image plates.


GE Healthcare has released DeCyder 2D 6.5 and DeCyder Extended Data Analysis 1.0. DeCyder 2D 6.5 is a Windows XP-based software package for analyzing the company's Ettan 2-D DIGE 2D gels. According to GE Healthcare, the new version offers automated image analysis, eliminates spot-matching within gels, and uses an internal standard designed to increase the measurement accuracy. DeCyder EDA 1.0 is integrated with DeCyder 2D 6.5 and allows researchers to combine their analysis of different data sets. DeCyder EDA uses multivariate analysis and clustering methods to uncover patterns in protein expression data from 2D DIGE experiments, the company said.


Chemical Computing Group has released MOE (Molecular Operating Environment) version 2005.06. The new release of the company's computational drug-design software includes new tools for bioinformatics, cheminformatics, high-throughput discovery, protein modeling, and structure-based design. New features include pharmacophore elucidation, automatic 2D depiction, ligand-receptor docking, and integration with MOPAC, GAMESS, and Gaussian.

 

Movers & Shakers

Frank Burgaezy, Roger Durst, and Bernard Kolodziej were all named executive vice presidents at Bruker AXS recently. The newly appointed executive management team will be responsible for all aspects of the firm's business, including global sales and marketing, customer support, manufacturing, research and development, operations, and financial management, the company said.

Burgaezy is now responsible for the firm's X-ray diffraction business as well as its X-ray fluorescence business, and also has global responsibility for marketing. He holds a doctorate in physics from the Max-Planck Institute in Stuttgart, Germany.

Durst heads Bruker's X-ray single crystal diffraction business, and is also the firm's chief technology officer. He holds a BS in aeronautics and astronautics from the Massachusetts Institute of Technology and a PhD in physics from the University of Texas at Austin.

Kolodziej is now head of global finance function and European operations, as well as worldwide subsidiaries, Bruker said. Kolodziej had served as vice president of finance since 2004. Kolodziej holds a MA in business administration, finance and production engineering from the University of Karlsruhe, Germany.


Nonlinear Dynamics has appointed Ian Currie as European sales manager. Currie joins the firm from Amersham Biosciences (now part of GE Healthcare) where he worked for six years as project manager for the development of the company's DeCyder 2D gel analysis software.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.